logo
AAT Bioquest

Somatostatin receptor 5 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
SomatostatinIC500.2 [1], 4.2 [2], 10.0 [3]
SomatostatinKi0.12 [1], 0.14 [2], 0.44 [3], 2.0 [4], 120.0 [5]
(4R,7S,10R,13S,16R,19S,22R,25S,28R,31S,34R,37S)-37-[[2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acidIC502.4 [1]
(4R,7S,10R,13S,16R,19S,22R,25S,28R,31S,34R,37S)-37-[[2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acidKi0.4 [1]
(4R,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acidIC5046.0 [1]
(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2S,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideIC500.77 [1], 21.8 [2]
(4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2S,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideKi5.01 [1], 6.8 [2], 11.53 [3]
(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-37-[[2-[[(2S)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-carboxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1S)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-2-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acidIC502.4 [1], 2.5 [2], 2.9 [3], 3.9 [4]
CID 5311374IC5010000.0 [1]
(4R,7S,10S,13S,16S,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,19,22-tribenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acidIC5014.0 [1], 16.0 [2]
H-DPhe-c[Cys-Phe-DTrp-Lys-Thr-Cys]-Thr-NH2IC502.7 [1], 5.1 [2]
2-(1-(4-Amino-3,5-diethoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-5-sulfonamideKi13.0 [1]
N-(1-(3-Ethoxy-4-methoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amineIC50740.0 [1]
N-(1-(3-Ethoxy-4-methoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amineKi121.0 [1]
N-[1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]-5-methylpyridine-3-carboxamideIC501.3 [1], 3.1 [2]
N-[1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]-5-methylpyridine-3-carboxamideKi4.4 [1]
4-[8-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.77 [1], 0.8 [2], 1.5 [3]
4-[8-[(4,4-Dimethyl-2,3-dihydrochromen-6-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC501.1 [1], 1.5 [2], 1.54 [3]
AstemizoleKi4070.0 [1]
SeglitideIC5081.0 [1]
SeglitideKi12.59 [1]
Cyclo(Pro-Phe-D-Trp-Lys-Thr-Phe)Ki25.0 [1], 39.81 [2]
8-D-Tryptophan-somatostatinIC503.1 [1]
8-D-Tryptophan-somatostatinKi0.46 [1]
(2S,3R)-2-[[(2S)-2-[(3S,6S,9S,12S,15S)-6-(4-Aminobutyl)-15-benzyl-12-[(4-hydroxyphenyl)methyl]-9-(1H-indol-3-ylmethyl)-2,5,8,11,14,20-hexaoxo-3-propan-2-yl-1,4,7,10,13,16,19-heptazacyclotricos-1-yl]-3-phenylpropanoyl]amino]-3-hydroxybutanamideIC5067.0 [1]
(2R,5R)-5-(4-Aminobutyl)-2-(1H-indol-3-ylmethyl)-7-(naphthalen-1-ylmethyl)-1,4,7-thiadiazonane-3,6-dioneIC5087.0 [1]
(4R,7S,10S,13R,16S,19S)-10-(4-Aminobutyl)-19-[[(2S)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideKi48.0 [1], 70.7 [2]
(4R,7S,10S,13S,16S,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-16-[(1S)-1-naphthalen-2-ylethyl]-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acidIC50147.0 [1], 360.0 [2]
(4R,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acidIC50199.0 [1]
(4R,7S,10S,13S,16R,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-19-[(4-hydroxyphenyl)methyl]-16-[(1S)-1-naphthalen-2-ylethyl]-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acidIC5018.0 [1], 668.0 [2]
2-(1-(3-Ethoxy-4-methoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-5-sulfonamideKi185.0 [1], 529.0 [2]
N-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-yl)-5-methylnicotinamideKi15.0 [1], 20.0 [2]
4-((4-(Benzo[d]oxazol-2-ylamino)piperidin-1-yl)methyl)-2-ethoxyphenolKi66.0 [1]
N-(1-(3-(Cyclopentyloxy)-4-methoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amineKi83.0 [1]
Benzooxazol-2-yl-[1-(3-isobutoxy-4-methoxy-benzyl)-piperidin-4-yl]-amineKi23.0 [1]
N-(1-(4-Methoxy-3-propoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amineKi293.0 [1]
N-(1-(3-Ethoxy-4-fluorobenzyl)piperidin-4-yl)benzo[d]oxazol-2-amineKi194.0 [1]
N-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-yl)benzo[d]oxazol-2-amineKi113.0 [1]
N-(1-(3-Ethoxy-4-methylbenzyl)piperidin-4-yl)benzo[d]oxazol-2-amineKi37.0 [1]
Des-AA1,2,5-[IAmp9,Tyr11]-SRIFIC501000.0 [1]
(3R,6S,9R,12S,15R,18S)-9-(4-Aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-18-[[(2R)-2-amino-3-phenylpropanoyl]amino]-15-benzyl-6-[(1R)-1-hydroxyethyl]-12-(1H-indol-3-ylmethyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacyclononadecane-3-carboxamideIC504.92 [1]
(2S,3R)-2-[[(3R,6S,9R,12S,15R,18S)-9-(4-Aminobutyl)-18-[[(2R)-2-amino-3-phenylpropanoyl]amino]-15-benzyl-6-[(1R)-1-hydroxyethyl]-12-(1H-indol-3-ylmethyl)-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacyclononadecane-3-carbonyl]amino]-3-hydroxybutanoic acidIC504.17 [1]
(4S,7R,10S,13R,16S,19R)-10-(4-Aminobutyl)-19-[[(2S)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxylic acidIC5010.95 [1]
(4R,7S,10R,13S,16R,19S,22S,25S,28R,31R,34S)-31-(4-Aminobutyl)-34-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-19-[[4-[(propan-2-ylamino)methyl]phenyl]methyl]-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacontane-4-carboxylic acidIC501000.0 [1]
SSTR5 antagonist 1IC509.6 [1]
(4R,7S,10S,13S,16S,19S,22S,25R)-25-Amino-13-(4-aminobutyl)-7,22-dibenzyl-10-[(1R)-1-hydroxyethyl]-16-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carboxylic acidIC50633.0 [1]
4-[2-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-5-oxa-2,6-diazaspiro[3.4]oct-6-en-7-yl]cyclohexane-1-carboxylic acidIC5030.0 [1], 130.0 [2]
4-[8-[[2-(2,4-Dichlorophenyl)-4-methyl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC502.4 [1], 3.2 [2]
4-[8-[[3,5-Dichloro-4-(trifluoromethoxy)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC5066.0 [1], 95.0 [2]
5-[(1R,3R)-1-(1-Ethylpyrazol-4-yl)-3-[5-(5-fluoropyridin-2-yl)-1H-imidazol-2-yl]-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]-3-methyl-1,3,4-oxadiazol-2-oneIC501530.0 [1], 9240.0 [2]
SSTR5 antagonist 2 (TFA)IC501.1 [1], 1.2 [2]
9-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-3-pyridin-3-ylsulfonyl-3,9-diazaspiro[5.5]undecaneIC5013.0 [1], 26.0 [2]
4-[8-[(7-Methyl-1-propan-2-ylindol-3-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acidIC5028.0 [1], 33.0 [2]
4-[8-[[4-(4-Fluorophenyl)-1-propan-2-ylindazol-3-yl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC50222.0 [1], 276.0 [2]
4-[8-[[2-(1-Methylpyrazol-4-yl)-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC501.0 [1], 5.5 [2]
4-[8-[(4-Cyclopropyl-1-propan-2-ylindol-3-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acidIC500.7 [1], 0.8 [2]
4-Chloro-2-[1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]oxypyrimidineIC5021.0 [1], 73.0 [2]
4-[1-(Benzenesulfonyl)piperidin-4-yl]-1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidineIC500.7 [1], 8.6 [2]
4-[8-[[4-Methyl-5-(trifluoromethyl)-2-(2,3,4-trifluorophenyl)phenyl]methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acidIC504.9 [1], 20.0 [2]
8-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-3-[(4-fluorophenyl)methyl]-1-oxa-8-azaspiro[4.5]decan-2-oneIC501.6 [1], 67.0 [2]
1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-4-[5-(4-fluorophenyl)-1H-imidazol-2-yl]piperidineIC507.6 [1], 247.0 [2]
4-[8-[[4-Chloro-2-cyclopropyl-5-(trifluoromethyl)phenyl]methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acidIC5019.0 [1], 37.0 [2]
4-[8-[(8-Chloro-4,4-dimethyl-2,3-dihydrochromen-6-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acidIC5024.0 [1], 30.0 [2]
4-[8-[(4,4-Dimethyl-2,3-dihydrochromen-6-yl)methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acidIC50109.0 [1], 161.0 [2]
8-[[1-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]piperidin-4-yl]methoxy]quinolineIC502.9 [1], 67.8 [2]
4-[8-[[4-(4-Fluorophenyl)-3,5-dimethylphenyl]methyl]-3-oxo-2,8-diazaspiro[4.5]decan-2-yl]benzoic acidIC5017.0 [1], 36.0 [2]
2-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acidIC5098.0 [1]
2-(1-(4-Chloro-3-ethoxybenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acidKi23.0 [1]
2-(1-(3,5-Diethoxy-4-fluorobenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acidIC5072.0 [1]
2-(1-(3,5-Diethoxy-4-fluorobenzyl)piperidin-4-ylamino)benzo[d]oxazole-6-carboxylic acidKi18.0 [1]
(2S)-6-Amino-N-benzyl-2-[(4R)-3-oxo-4-[(2-phenylacetyl)amino]-1,4,5,10-tetrahydroazepino[3,4-b]indol-2-yl]hexanamideIC501.2 [1]
8-[[3,5-Diethoxy-4-(4-fluorophenyl)phenyl]methyl]-1,3,8-triazaspiro[4.5]decane-2,4-dioneIC5083.0 [1], 110.0 [2]
(4R,7S,10S,13R,16S,19S)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideIC50218.0 [1]
(4R,7S,10S,13R,16S,19S)-10-(4-Aminobutyl)-19-[[(2R)-2-amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideKi48.0 [1]
(4R,7S,10S,13R,16S,19S)-19-[[(2R)-2-Amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-10-[4-(methylamino)butyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideIC5053.0 [1]
(4R,7S,10S,13R,16S,19S)-19-[[(2R)-2-Amino-3-(4-chlorophenyl)propanoyl]amino]-N-[(2S)-1-amino-3-naphthalen-2-yl-1-oxopropan-2-yl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-10-[4-(methylamino)butyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamideKi50.0 [1]
SSTR5 antagonist 2IC501.1 [1], 1.2 [2]
5-[[(2R,3R,4R,5S)-1-[2-(1H-Indol-3-yl)ethyl]-3,4,5-tris(phenylmethoxy)piperidin-2-yl]methoxy]pentan-1-amineKi5000.0 [1]
4-[8-[(4,4-Dimethyl-2,3-dihydrothiochromen-6-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.6 [1], 1.5 [2]
4-[8-[[3-Cyclopropyl-4-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC501.2 [1], 1.8 [2]
4-[8-[(4-Cyclopropyl-1-propan-2-ylindol-3-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.1 [1], 0.3 [2]
4-[8-[(2,2-Dimethyl-3,4-dihydrochromen-8-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC507.9 [1], 8.4 [2]
4-[8-[[4-Methyl-2-pyridin-4-yl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.8 [1], 2.9 [2]
2-[[(3As,6aR)-1-[[3,5-diethoxy-4-(4-fluorophenyl)phenyl]methyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-4-yl]amino]-1,3-benzoxazole-6-carboxylic acidIC502.5 [1], 4.5 [2]
4-[8-[[2-Cyclopropyl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC502.1 [1], 2.4 [2]
4-[8-[(4,4-Dimethyl-1,1-dioxo-2,3-dihydrothiochromen-6-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC5030.0 [1], 31.0 [2]
4-[8-[[4-Cyclopropyl-3-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC503.2 [1], 4.1 [2]
4-[8-[(5-Cyclopropyl-2-methoxypyridin-3-yl)methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC505.7 [1], 8.2 [2]
4-[8-[[4-Chloro-2-cyclopropyl-5-(trifluoromethyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.4 [1], 0.7 [2]
4-[8-[[4-(4-Fluorophenyl)-1-propan-2-ylpyrrolo[2,3-b]pyridin-3-yl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.4 [1]
4-[2-Oxo-8-[[1-propan-2-yl-4-(2,3,4-trifluorophenyl)indol-3-yl]methyl]-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.2 [1], 0.5 [2]
4-[8-[[4-Methyl-5-(trifluoromethyl)-2-(2,3,4-trifluorophenyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC501.2 [1], 3.2 [2]
4-[8-[[3-Chloro-5-cyclopropyl-4-(2,4-difluorophenyl)phenyl]methyl]-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-3-yl]benzoic acidIC500.2 [1], 0.4 [2]
LanreotideKi3.98 [1]
PasireotideKi0.13 [1]
EdotreotideIC50393.0 [1]
VapreotideKi5.01 [1]
(4R,7S,10S,13S,16S,19S,22R,25S,28S,31S,34R)-34-Amino-31-(4-aminobutyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33-decaoxo-19-[[4-[(propan-2-ylamino)methyl]phenyl]methyl]-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacontane-4-carboxylic acidIC501000.0 [1]
CID 5311375IC500.4 [1]
[(2S)-2-Aminopropyl] (2R)-6-amino-2-[[2-(2-naphthalen-2-yl-1H-benzo[g]indol-3-yl)acetyl]amino]hexanoateIC500.4 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Somatostatin receptor 5 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.20 Nov2024https://www.aatbio.com/data-sets/somatostatin-receptor-5-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024November 20). Quest Database™ Somatostatin receptor 5 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/somatostatin-receptor-5-inhibitors-ic50-ki.
BibTeXEndNoteRefMan